In a new landmark publication in The Lancet, a global effort involving academic, clinical and patient organizations has moved the needle on recognizing the whole-body impacts of Polyendocrine Metabolic Ovarian Syndrome (PMOS) – formerly known as Polycystic Ovary Syndrome (PCOS). In this perspectives piece, Dr. Shruthi Mahalingaiah details her thoughts.